Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.96 |
| ▸ | CA9 | Q16790 | 7/20 | 0.96 |
| ▸ | CA2 | P00918 | 5/20 | 0.96 |
| ▸ | CA1 | P00915 | 4/20 | 0.96 |
| ▸ | CA7 | P43166 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | CA4 | P22748 | 2/20 | 0.96 |
| ▸ | USP2 | O75604 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 1/20 | 0.96 |
| ▸ | BCHE | P06276 | 1/20 | 0.96 |
| ▸ | CA6 | P23280 | 1/20 | 0.96 |
| ▸ | CA5A | P35218 | 1/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.96 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.96 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | RET | P07949 | 2/20 | 0.53 |
| ▸ | GRK5 | P34947 | 2/20 | 0.53 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.53 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL3373 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL10627242 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL3374 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL8802065 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL10899217 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL11399526 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL4624412 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL9463482 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL9463164 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL8214948 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117638200-B | Lithium ion battery and electronic device | 宁德新能源科技有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117638200-A | Lithium ion battery and electronic device | 宁德新能源科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| EP-3141239-B1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | PROCTER & GAMBLE (US) | 2023-05-10 | — | — | EP | claimed |
| EP-2780748-B1 | A SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING | NOVARTIS AG (CH) | 2016-01-13 | — | — | EP | claimed |
| EP-2718751-B1 | SILICONE HYDROGEL LENSES WITH NANO-TEXTURED SURFACES | NOVARTIS AG (CH) | 2015-07-22 | — | — | EP | claimed |
| EP-2780748-A1 | A SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING | Novartis AG (CH) | 2014-09-24 | — | — | EP | claimed |
| EP-2718751-A1 | SILICONE HYDROGEL LENSES WITH NANO-TEXTURED SURFACES | Novartis AG (CH) | 2014-04-16 | — | — | EP | claimed |
| WO-2013074535-A1 | A SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING | NOVARTIS AG (CH) | 2013-05-23 | — | — | WO | claimed |
| WO-2012170603-A1 | SILICONE HYDROGEL LENSES WITH NANO-TEXTURED SURFACES | NOVARTIS AG (CH) | 2012-12-13 | — | — | WO | claimed |
| EP-4396617-A1 | A METHOD FOR PRODUCING WETTABLE SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2024-07-10 | — | — | EP | disclosed |
| EP-3724696-B1 | WEEKLY AND MONTHLY DISPOSABLE WATER GRADIENT CONTACT LENSES | ALCON INC (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240176047-A1 | WEEKLY AND MONTHLY DISPOSABLE WATER GRADIENT CONTACT LENSES | ALCON INC. (CH) | 2024-05-30 | — | — | US | disclosed |
| EP-2705808-B1 | Silicone hydrogel lenses with water-rich surfaces | ALCON INC (CH) | 2024-05-01 | — | — | EP | disclosed |
| CN-117638200-B | Lithium ion battery and electronic device | 宁德新能源科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| EP-1363580-A2 | COMPOSITIONS HAVING ANTI-DENTAL CARIES FUNCTION | Ezaki Glico Co., Ltd. (JP) | 2003-11-26 | — | — | EP | disclosed |
| US-20030087875-A1 | Hypersulfated disaccharides and methods of using the same for the treatment of inflammations | IVAX RESEARCH HOLDINGS, INC. | 2003-05-08 | — | — | US | disclosed |
| WO-2003020735-A1 | SACCHARIDE SULFATION METHODS | IVAX RESEARCH, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2002083700-A2 | HYPERSULFATED DISACCHARIDES AND METHODS OF USING THE SAME FOR THE TREATMENT OF INFLAMMATIONS | IVAX RESEARCH, INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002067871-A2 | COMPOSITIONS HAVING ANTI-DENTAL CARIES FUNCTION | EZAKI GLICO CO., LTD. (JP) | 2002-09-06 | — | — | WO | disclosed |
| CN-1192673-A | Composition and method for remineralization of teeth | ENAMELON INC (US) | 1998-09-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087875-A1 | Hypersulfated disaccharides and methods of using the same for the treatment of inflammations | IL5, LTC4S, CD44 | CA12 457/4885CA9 651/4885CA2 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.